xCures Expands AI Health Data Platform: Now Supporting All Therapeutic Areas and is Available as SaaS

The company’s platform expansion transforms the value of US healthcare data by harnessing real-time, regulatory-grade data in any therapeutic area to efficiently understand the complex medical histories of patients and drive research through detailed, longitudinal datasets.

xCures, a trailblazer in healthcare technology, announced today the expansion of its AI-assisted medical data platform to support real-time, regulatory-grade data in any therapeutic area. Originally designed as a tool focused specifically on cancer, the company’s platform expansion now serves as a comprehensive tool to collect and understand medical records for any US patient with any condition.

Harnessing AI/ML technology, xCures’ platform gathers records, extracts, and aggregates data, including organizing and structuring clinical, genomic, and imaging information from diverse sources, into a searchable digital record. This solution can help any user looking to quickly find or assess key clinical information about a patient for care-related activities. This integrated approach transforms how medical professionals and researchers can understand complex patients and cohort characteristics.

Recommended AI News: Resonate ‘State of the Consumer’ Report Reveals New Insights for 2024

C**** makes this technology available through software licenses to the platform and direct API connections embedded within existing healthcare workflow management platforms.  The system offers a patient-centric, longitudinal perspective crucial for informed decision-making.

This evolution marks another advancement that will significantly benefit those making data-driven healthcare decisions.  Because the collected data can also be de-identified it can be available for secondary research;  xCures provides the most comprehensive patient-centric longitudinal data in the form of deidentified real-world datasets that contain comprehensive insights across all providers and care locations.

Recommended AI News: GSMA and IBM Collaborate to Accelerate AI Adoption and Skills for the Telecoms Sector

“Expanding our AI platform beyond oncology marks a significant milestone in our mission to transform the value of healthcare data,” said Mika Newton, CEO of xCures. “We’re providing access to a software platform that generates precise real-world data at the individual and cohort levels across all diseases that will accelerate groundbreaking research across many fields and directly benefit patients. ”

With its ability to aggregate and interpret diverse medical records quickly and accurately, xCures’ platform is a game-changer for anyone working to access and interpret retrospective and prospective healthcare or real-world data. It facilitates an in-depth understanding of medical patterns and conditions and enhances the scope of clinical trials and research across various diseases. Making this technology available across the healthcare ecosystem as a platform solution transforms the opportunity to leverage US healthcare data.

Recommended AI News: UserTesting Elevates Human Insight Platform with AI Summary and Enhanced Features

[To share your insights with us as part of editorial or sponsored content, please write to sghosh@martechseries.com]